170 related articles for article (PubMed ID: 26134369)
1. MiR-17-5p as circulating biomarkers for the severity of coronary atherosclerosis in coronary artery disease.
Chen J; Xu L; Hu Q; Yang S; Zhang B; Jiang H
Int J Cardiol; 2015 Oct; 197():123-4. PubMed ID: 26134369
[No Abstract] [Full Text] [Related]
2. Translating the microRNA signature of microvesicles derived from human coronary artery smooth muscle cells in patients with familial hypercholesterolemia and coronary artery disease.
de Gonzalo-Calvo D; Cenarro A; Garlaschelli K; Pellegatta F; Vilades D; Nasarre L; Camino-Lopez S; Crespo J; Carreras F; Leta R; Catapano AL; Norata GD; Civeira F; Llorente-Cortes V
J Mol Cell Cardiol; 2017 May; 106():55-67. PubMed ID: 28342976
[TBL] [Abstract][Full Text] [Related]
3. Plasma MicroRNA-126-5p is Associated with the Complexity and Severity of Coronary Artery Disease in Patients with Stable Angina Pectoris.
Li HY; Zhao X; Liu YZ; Meng Z; Wang D; Yang F; Shi QW
Cell Physiol Biochem; 2016; 39(3):837-46. PubMed ID: 27497911
[TBL] [Abstract][Full Text] [Related]
4. Circulating MicroRNAs as Novel Diagnostic Biomarkers for Very Early-onset (≤40 years) Coronary Artery Disease.
DU Y; Yang SH; Li S; Cui CJ; Zhang Y; Zhu CG; Guo YL; Wu NQ; Gao Y; Sun J; Dong Q; Liu G; Li JJ
Biomed Environ Sci; 2016 Aug; 29(8):545-554. PubMed ID: 27660218
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease.
Jansen F; Yang X; Proebsting S; Hoelscher M; Przybilla D; Baumann K; Schmitz T; Dolf A; Endl E; Franklin BS; Sinning JM; Vasa-Nicotera M; Nickenig G; Werner N
J Am Heart Assoc; 2014 Oct; 3(6):e001249. PubMed ID: 25349183
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNAs as potential biomarkers for coronary plaque rupture.
Li S; Lee C; Song J; Lu C; Liu J; Cui Y; Liang H; Cao C; Zhang F; Chen H
Oncotarget; 2017 Jul; 8(29):48145-48156. PubMed ID: 28624816
[TBL] [Abstract][Full Text] [Related]
7. Alteration in microRNA-155 level correspond to severity of coronary heart disease.
Qiu XK; Ma J
Scand J Clin Lab Invest; 2018 May; 78(3):219-223. PubMed ID: 29411649
[TBL] [Abstract][Full Text] [Related]
8. Association between elevated plasma microRNA-223 content and severity of coronary heart disease.
Guo JF; Zhang Y; Zheng QX; Zhang Y; Zhou HH; Cui LM
Scand J Clin Lab Invest; 2018 Sep; 78(5):373-378. PubMed ID: 29888618
[TBL] [Abstract][Full Text] [Related]
9. Altered Plasma miR-144 as a Novel Biomarker for Coronary Artery Disease.
Chen B; Luo L; Wei X; Gong D; Jin L
Ann Clin Lab Sci; 2018 Jul; 48(4):440-445. PubMed ID: 30143484
[TBL] [Abstract][Full Text] [Related]
10. Association between circulating microRNA-208a and severity of coronary heart disease.
Zhang Y; Li HH; Yang R; Yang BJ; Gao ZY
Scand J Clin Lab Invest; 2017 Sep; 77(5):379-384. PubMed ID: 28554251
[TBL] [Abstract][Full Text] [Related]
11. Circulatory miR-133b and miR-21 as Novel Biomarkers in Early Prediction and Diagnosis of Coronary Artery Disease.
Kumar D; Narang R; Sreenivas V; Rastogi V; Bhatia J; Saluja D; Srivastava K
Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32033332
[TBL] [Abstract][Full Text] [Related]
12. Potential value of circulating microRNA-126 and microRNA-210 as biomarkers for type 2 diabetes with coronary artery disease.
Amr KS; Abdelmawgoud H; Ali ZY; Shehata S; Raslan HM
Br J Biomed Sci; 2018 Apr; 75(2):82-87. PubMed ID: 29452547
[TBL] [Abstract][Full Text] [Related]
13. miR-342-5p Expression Levels in Coronary Artery Disease Patients and its Association with Inflammatory Cytokines.
Ahmadi R; Heidarian E; Fadaei R; Moradi N; Malek M; Fallah S
Clin Lab; 2018 Apr; 64(4):603-609. PubMed ID: 29739089
[TBL] [Abstract][Full Text] [Related]
14. Circulating endothelium-enriched microRNA-126 as a potential biomarker for coronary artery disease in type 2 diabetes mellitus patients.
Al-Kafaji G; Al-Mahroos G; Abdulla Al-Muhtaresh H; Sabry MA; Abdul Razzak R; Salem AH
Biomarkers; 2017; 22(3-4):268-278. PubMed ID: 27321479
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-21 is a unique signature associated with coronary plaque instability in humans by regulating matrix metalloproteinase-9 via reversion-inducing cysteine-rich protein with Kazal motifs.
Fan X; Wang E; Wang X; Cong X; Chen X
Exp Mol Pathol; 2014 Apr; 96(2):242-9. PubMed ID: 24594117
[TBL] [Abstract][Full Text] [Related]
16. miRNA 206 and miRNA 574-5p are highly expression in coronary artery disease.
Zhou J; Shao G; Chen X; Yang X; Huang X; Peng P; Ba Y; Zhang L; Jehangir T; Bu S; Liu N; Lian J
Biosci Rep; 2015 Dec; 36(1):e00295. PubMed ID: 26685009
[TBL] [Abstract][Full Text] [Related]
17. Role of miR-128-3p and miR-195-5p as biomarkers of coronary artery disease in Indians: a pilot study.
Choudhury RR; Gupta H; Bhushan S; Singh A; Roy A; Saini N
Sci Rep; 2024 May; 14(1):11881. PubMed ID: 38789551
[TBL] [Abstract][Full Text] [Related]
18. Circulating microRNAs in patients with coronary artery disease.
Fichtlscherer S; De Rosa S; Fox H; Schwietz T; Fischer A; Liebetrau C; Weber M; Hamm CW; Röxe T; Müller-Ardogan M; Bonauer A; Zeiher AM; Dimmeler S
Circ Res; 2010 Sep; 107(5):677-84. PubMed ID: 20595655
[TBL] [Abstract][Full Text] [Related]
19. Circulating microRNAs (miR-423-5p, miR-208a and miR-1) in acute myocardial infarction and stable coronary heart disease.
Nabiałek E; Wańha W; Kula D; Jadczyk T; Krajewska M; Kowalówka A; Dworowy S; Hrycek E; Włudarczyk W; Parma Z; Michalewska-Włudarczyk A; Pawłowski T; Ochała B; Jarząb B; Tendera M; Wojakowski W
Minerva Cardioangiol; 2013 Dec; 61(6):627-37. PubMed ID: 24253456
[TBL] [Abstract][Full Text] [Related]
20. miR-126: A Potential Biomarker for Coronary Artery Disease?
He X; Xu J
Cardiology; 2019; 142(1):2-3. PubMed ID: 30852566
[No Abstract] [Full Text] [Related]
[Next] [New Search]
